In colon cancer, the beneficial prognostic impact of high SATB2 expression (NS>9) was even more accentuated (Figures 2B and E), whereas no prognostic value was seen for SATB2 expression in rectal cancer (Figure 2C and F). The gene discussed is SATB2; the disease is colonic neoplasm.